Tradestie Institutional Equity Comparison Engine

MRK vs EQ โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-19 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

MRK Overall Edge

MRK Captures Institutional Edge (3โ€“1 Pillars ยท 8โ€“2 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Merck & Co., Inc. (MRK) driven by superior Growth & Margin, Momentum & Technical, Options & Structure while EQ counters with relative strength in Valuation. Fundamentally, MRK trades at 14.8x Forward P/E with 35.2% operating margin (+4.7% YoY revenue) versus EQ at 1.5x Forward P/E and 0.0% operating margin (-52.3% YoY). In options structure, MRK sits in CONSOLIDATION (28th %ile IV; Dealer Gamma Walls on Pro) against EQ sits in UNCLASSIFIED (100th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner EQ
MRK 14.8x vs EQ 1.5x Fwd P/E
Growth & Margin Winner MRK
Op Margin 35.2% vs 0.0% ยท YoY +4.7% vs -52.3%
Momentum & Technical Winner MRK
1Y +37.7% vs +12.0% ยท 52W Pos 63% vs 11%
Options & Structure Winner MRK
CONSOLIDATION (28th %ile IV) vs UNCLASSIFIED (100th %ile IV)
MRK NYSE
Merck & Co., Inc.
Pharmaceutical Preparations
$132.81
-3.61% 1D
Market Cap $339.7B
1M Return -11.39%
1Y Return +37.73%
Forward P/E 14.8x
Unified AI Score
50.8 / 100 HOLD
Tech 23.0 Fund 47.0 Flow 68.0 Mom 60.0
EQ NASDAQ
Equillium, Inc. Common Stock
Pharmaceutical Preparations
$1.12
+1.82% 1D
Market Cap $90.6M
1M Return -21.13%
1Y Return +12.0%
Forward P/E 1.5x
Unified AI Score
48.0 / 100 HOLD
Tech 30.0 Fund 51.0 Flow 63.0 Mom 60.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: MRK +37.73% EQ +12.0% Spread: +25.73 pp (MRK Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period MRK Revenue EQ Revenue MRK Op. Margin EQ Op. Margin Margin Edge
FY2018 $42.3B N/A 14.7% N/A MRK
FY2019 $39.1B N/A 25.2% N/A MRK
FY2020 $41.5B N/A 17.0% N/A MRK
FY2021 $48.7B N/A 26.8% N/A MRK
FY2022 $59.3B $20M 24.5% -393.9% MRK
FY2023 $60.1B $40M 0.6% -40.2% MRK
FY2024 $64.2B $40M 26.7% -20.1% MRK
FY2025 $65.0B N/A 28.1% N/A MRK

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: MRK (8) vs EQ (2)
Institutional Metric MRK EQ Criterion Row Winner
Market Capitalization Scale $339.7B $90.6M Larger Scale MRK
Trailing P/E Ratio Valuation 139.2x 1.5x Lower Multiple EQ
Forward P/E Ratio Valuation 14.8x 1.5x Lower Multiple EQ
Revenue Growth (YoY) Growth +4.7% -52.3% Higher Growth MRK
Operating Margin (TTM) Profitability 35.2% 0.0% Higher Margin MRK
Net Profit Margin Profitability 3.6% 0.0% Higher Margin MRK
Return on Equity (ROE) Capital Efficiency 5.1% -59.0% Higher ROE MRK
52-Week Range Position Momentum 63% ($92โ€“$157) 11% ($1โ€“$4) Stronger Trend MRK
Beta / 30D Volatility Risk Regime 0.27ฮฒ ยท 34% Vol 1.53ฮฒ ยท 93% Vol Lower Realized Risk MRK
Unified Institutional Score Composite Signal 50.8 / 100 (HOLD) 48.0 / 100 (HOLD) Higher Composite MRK

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full MRK vs EQ Buy Guide
MRK CONSOLIDATION
61d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 28th %ile
IV Regime Balanced (25thโ€“60th %ile)
Live MRK Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
EQ UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 100th %ile
IV Regime Extreme (>80th %ile)
Live EQ Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither MRK nor EQ registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.